- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01976897
Effect of the Physiological Angular Position of the Resting Knee on Pressure at the Heel/Surface Interface (FlessCare)
Study Overview
Status
Conditions
Detailed Description
The secondary objectives of this study are:
A. To evaluate the relationship between the angle of flexion of the knee in DDPD and the average pressure throughout the heel area (Pmean).
B. To evaluate the relationship between the angle of flexion of the knee in DDPD and the contact surface of the heel area (Stal) where the pressure is greater than 60 mm Hg.
C. To evaluate the inter-operator concordance for the knee flexion angle measurement in DDPD via photos.
D. To evaluate the inter-operator concordance for skin marks used to measure knee flexion angles in DDPD via photos (only one knee for 30 patients).
E. To evaluate the inta-operator concordance (measures on 2 consecutive days) for skin marks used to measure knee flexion angles in DDPD via photos (for 30 patients).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Nîmes Cedex 9, France, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is in a stable medical state (no complications within the past 10 days)
Exclusion Criteria:
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient has had medical complications within the ten days preceding study inclusion
- The patient has a bed-sore or bandages on his/her heels
- The patient has had a lower-limb amputation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
The study population
Only one group is included. See inclusion/exclusion criteria. Intervention: Knee flexion measurement 1 Intervention: Knee flexion measurement 2 Intervention: Heel - interface pressure measurements |
The angle of knee flexion during resting, supine position is measured by a first person.
The angle of knee flexion during resting, supine position is measured by a second person.
The pressure analysis system used is the X Sensor X3 model (Xsensor Technology Corporation, Calgary, Canada). The sensor mat is made up of transducer cells, each measuring 1.6 cm^2. The digital signal is transmitted to a PC via a USB port at a sampling frequency of 10Hz. Before each measurement, the sensor mat is calibrated from 10 to 220 mm Hg, according to the manufacturer's recommendations. The sheet of pressure sensors is disposed on the dedicated bed. The patient is then asked to take his/her usual position in the supine position and a latency of 5 minutes is observed. The recording time pressure is then performed for 90 seconds in the optical observing time to adapt to changes in media. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Measurement 1: Measurement of the knee joint angle (degrees °) in a physiological relaxed position (supine)(via photos of first skin marks).
Time Frame: Day 0
|
Day 0
|
|
Measurement 2: Measurement of the knee joint angle (degrees °) in a physiological relaxed position (supine)(via photos of first skin marks)
Time Frame: Day 0
|
Day 0
|
|
Maximum pressure on the heel area (Ptal)
Time Frame: Day 0
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean pressure over the entire heel area (P mean)
Time Frame: Day 0
|
Day 0
|
|
|
Measurement of the contact surface of the heel zone (Stal) having a pressure greater than 60 mmHg
Time Frame: Day 0
|
Day 0
|
|
|
Concordance for measurements 1 & 2 for knee flexion angle in a relaxed supine position (via photos)
Time Frame: Day 0
|
Day 0
|
|
|
Concordance for skin marks for knee flexion angles between 2 operators for 30 knees.
Time Frame: Day 0
|
relaxed, decubitus dorsal position
|
Day 0
|
|
Intra-operator concordance for skin marks used for measuring knee flexion angle for 30 knees
Time Frame: Day 1
|
Relaxed decubitus dorsal position
|
Day 1
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Age
Time Frame: Day 0
|
Day 0
|
|
Sex
Time Frame: Day 0
|
Day 0
|
|
Weight (kg)
Time Frame: Day 0
|
Day 0
|
|
Height (cm)
Time Frame: Day 0
|
Day 0
|
|
Braden risk scale
Time Frame: Day 0
|
Day 0
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LOCAL/2013/EVFN-01
- 2013-A01063-42 (OTHER: RCB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.